Cadila’s stock was primed by a series of potential roll outs to meet the COVID-19 challenge. Beyond COVID, the company is steadily building up its injectable and biosimilars portfolio - the areas to look at for the longer term.
first published: May 28, 2021 07:12 pm
A collection of the most-viewed Moneycontrol videos.
Live: Sensex, Nifty retreat after mounting on new lifetime highs | Closing Bell
Live: Will bulls take Nifty to fresh lifetime highs today? | Opening Bell
Live: Nifty sees best single day rally since June 2025, nears record high | Closing Bell
Live: Can Nifty claim new lifetime highs in December series? | Opening Bell
Is it a good time to enter Bajaj Finance post Q3 business update? | Opening Bell
Attractive valuation, strong earnings potential: Buy this stock for the long term | Ideas for Profit
Vesuvius India made fresh lifetime high. Right time to buy the stock or wait for a drop?
Indian Hotel Industry Sees Strong Demand; Buy This Stock For Sector Upcycle | Ideas For Profit
Can strong auto demand drive this company’s stock further? | Ideas For Profit
